← Eichor
Condition: Anatomic Stage I Breast Cancer Ajcc V8 Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Anatomic Stage I Breast Cancer Ajcc V8

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Enhancing Skin Appearance and Quality of Life in Breast Cancer Survivors on Aromatase Inhibitor Therapy
Phase N/A · 1 location(s) · Mayo Clinic · NCT06401889Manual Lymphatic Drainage Breast Massage in Breast Cancer Patients After Breast Conserving Surgery
NA · 1 location(s) · University of Southern California · NCT06297265Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors
Phase 1/Phase 2 · 1 location(s) · Mayo Clinic · NCT05269381Topical or Oral Minoxidil for the Treatment of Endocrine Therapy-Induced Alopecia in Patients With Stage I-IV Breast Can
EARLY_Phase 1 · 1 location(s) · Ohio State University Comprehensive Cancer Center · NCT05417308Online Nutrition Education to Decrease the Side Effects of Chemotherapy in Patients With Breast Cancer
NA · 1 location(s) · Fred Hutchinson Cancer Center · NCT05874297Dose-Reduced Docetaxel With Cyclophosphamide for the Treatment of Vulnerable Older Women With Stage I-III HER2 Negative
Phase 2 · 3 location(s) · City of Hope Medical Center · NCT06042569Fisetin to Improve Physical Function in Stage I-III Breast Cancer Survivors
Phase 2 · 7 location(s) · Jonsson Comprehensive Cancer Center · NCT05595499Active Surveillance in Older Women With ER+ Breast Cancer
Phase N/A · 1 location(s) · University of Pittsburgh · NCT072621385-strain Probiotic Formulation in HR-positive Breast Cancer Receiving Aromatase Inhibitor to Prevent Bone Loss
Phase 2 · 1 location(s) · Mayo Clinic · NCT07044310TeleHealth Resistance Exercise Intervention to Preserve Dose Intensity and Vitality in Elder Breast Cancer Patients
NA · 4 location(s) · Dana-Farber Cancer Institute · NCT05535192Neoadjuvant Neratinib in Stage I-III HER2-Mutated Lobular Breast Cancers
Phase 2 · 5 location(s) · Vanderbilt-Ingram Cancer Center · NCT05919108A Vaccine (MV-s-NAP) for the Treatment of Patients With Invasive Metastatic Breast Cancer
Phase 1 · 1 location(s) · Mayo Clinic · NCT04521764Pre-operative SABR With and Without Caloric Restriction for Early Stage Breast Cancer
NA · 1 location(s) · Thomas Jefferson University · NCT04959474Evaluation of Alternative Site Goserelin Acetate Injection for Ovarian Function Suppression (OFS) in Local and Locally A
Phase 2 · 1 location(s) · Mayo Clinic · NCT07460752Ph2 Study for Optimization of Adjunct Systemic Therapy in HER2+ Patients, MolecularPCR Trial
Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT07407920Comparison Between Prepectoral and Subpectoral Breast Reconstruction
Phase N/A · 1 location(s) · Beijing Friendship Hospital · NCT05833659A Study of Revaree Plus in People With Breast Cancer
Phase 4 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT07042581Breast Cancer, Reasoning, and Activity Intervention
NA · 1 location(s) · Mayo Clinic · NCT04816006Breast Cancer Survivorship Biorepository
Phase N/A · 1 location(s) · University of Southern California · NCT05786664A Study of Disappearing Markers for Daily Radiation Treatment Delivery for Breast Cancer Patients.
NA · 1 location(s) · Barbara Ann Karmanos Cancer Institute · NCT07095114Testing Laser Therapy for Treatment of Vaginal Dryness in Survivors of Breast Cancer, The Revitalize Trial
Phase 3 · 2 location(s) · Alliance for Clinical Trials in Oncology · NCT05379153Ultra-hypofractionated Whole Breast Irradiation With Lumpectomy Cavity Boost for the Treatment of Stage I-III Breast Can
Phase 2 · 7 location(s) · City of Hope Medical Center · NCT06954831Acutherapy to Prevent Aromatase Inhibitor-Associated Arthralgias in Non-Hispanic Black Postmenopausal Women With Early-S
NA · 4 location(s) · Emory University · NCT06534125Metformin for the Treatment of Insulin Resistance in Women With Stage I-III Breast Cancer Completing Chemotherapy
Phase 3 · 3 location(s) · City of Hope Medical Center · NCT06763328Evaluating the Association Among Changes in Gut Microbiome, Fatigue, and Chemotherapy-Induced Nausea in Early Stage Brea
Phase N/A · 5 location(s) · Mayo Clinic · NCT05417867Immune Response to Anti-HER2 Therapies in Patients With HER2-Positive Stage I-IV Breast Cancer
Phase N/A · 1 location(s) · Mayo Clinic · NCT04517838Personalized Vaccine Immunotherapy in Combination With Checkpoint Inhibitor for Treatment of Triple Negative Breast Canc
Phase 1 · 4 location(s) · Emory University · NCT06324240Remotely Delivered, Community-Aligned Weight Loss Interventions Among Breast Cancer Survivors, ¡Vida! Trial
NA · 1 location(s) · Fred Hutchinson Cancer Center · NCT05930483Improving Exercise Capacity With a Tailored Physical Activity Intervention
NA · 2 location(s) · Wake Forest University Health Sciences · NCT05595577Leuprolide and Goserelin for Ovarian Function Suppression in Pre- or Peri-menopausal Women With Breast Cancer, OFS Trial
Phase 2 · 1 location(s) · University of Michigan Rogel Cancer Center · NCT07158021
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.